Try our Advanced Search for more refined results

June 13, 2016

Genzyme Corporation v. Dr. Reddy's Laboratories, Ltd

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. December 18, 2017

    Fed. Circ. Upholds Genzyme's Win In Stem Cell Patent Case

    The Federal Circuit on Monday affirmed a Delaware federal judge's finding in a bench trial that a Genzyme Corp. patent on harvesting stem cells is valid, leaving in place a ruling that barred generic versions of the cancer drug Mobozil planned by Dr. Reddy's and Teva.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!